Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae
Microalgae exhibit great potential for recombinant therapeutic protein production, due to lower production costs, immunity to human pathogens, and advanced genetic toolkits. However, a fundamental aspect to consider for recombinant biopharmaceutical production is the presence of correct post-transla...
Main Authors: | Lorenzo Barolo, Raffaela M. Abbriano, Audrey S. Commault, Jestin George, Tim Kahlke, Michele Fabris, Matthew P. Padula, Angelo Lopez, Peter J. Ralph, Mathieu Pernice |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/633 |
Similar Items
-
Proteomic analysis reveals molecular changes following genetic engineering in Chlamydomonas reinhardtii
by: Lorenzo Barolo, et al.
Published: (2024-10-01) -
Glyco-engineering for biopharmaceutical production in moss bioreactors
by: Eva L. Decker, et al.
Published: (2014-07-01) -
Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects
by: Alex van der Kaaij, et al.
Published: (2022-04-01) -
Editorial: Insights into glyco-parasitology
by: Kentaro Kato, et al.
Published: (2024-05-01) -
Development, Production, and Application of Recombinant Yeast Biocatalysts in Organic Synthesis
by: Roland Wohlgemuth
Published: (2005-10-01)